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INTRODUCTION 
The pathogenesis of hemorrhagic shock is acute severe 
blood loss. The consequences of this blood loss affect 
every organ system to some extent. The interaction of organ 
systems is so complex, and our present understanding of 
patho-physiology in this area is so meager that despite the 
voluminous literature published on the subject, there is 
still no unifying theory to explain all of the pathologic 
mechanisms occurring during hemorrhagic shock. 
Remington et al.^ have studied the most obvious aspect 
of hemorrhagic shock, the circulatory response. Thirty dogs 
were bled in stages to a mean arterial pressure of fifty 
millimeters mercury. The observations on the animals’ cir¬ 
culatory systems were divided into three phases. In phase 
one, the arterial systolic and diastolic blood pressures 
fell, the pulse pressure narrowed, the heart rate did not 
increase (thus cardiac output fell), and the peripheral 
resistance increased slightly. In phase two, the diastolic 
pressure remained constant although the mean blood pressure 
fell as the pulse pressure decreased, the heart rate 
increased (so did cardiac output), and peripheral resistance 
again increased slightly. In phase three, arterial blood 
pressure fell rapidly, peripheral resistance decreased, car¬ 
diac output decreased, the heart size increased terminally 
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while the central venous pressure remained constant or 
increased, and all dogs died. Remington’s group concluded 
that by phase three the arterioles became so hypoxic as to 
become unresponsive to vasoconstrictive influences, leading 
to a fatal expansion of the arterial tree. 
The concept of ultimate peripheral vascular failure in 
shock has been accepted and extended by some groups to 
explain the most puzzling aspect of hemorrhagic shock, irre¬ 
versible shock. It is well known that beyond a certain time, 
a re-infusion of lost blood will not prevent continued cardio 
vascular deterioration. If dogs are kept in a state of 
hemorrhagic shock long enough, it has been observed that they 
will spontaneously auto-transfuse themselves by sucking in 
shed blood which has been held in reservoirs. This phenom¬ 
enon is presumed to be due to a failure to maintain a fixed 
arterial blood pressure and is taken by most experimenters 
to be the earliest indication of irreversible shock, 
2 
weidner et al, bled twenty-seven dogs to a mean arterial 
blood pressure of twenty-five to thirty millimeters mercury 
and kept the pressure at this level until the dogs auto- 
transfused some of their shed blood. At this point, the 
authors re-infused all of the remaining blood. Using a 
strain gauge to measure the force of myocardial contraction, 
they found that except for the period just prior to death, 
the blood pressures fell after re-infusion of all lost blood 
while the myocardial force remained normal or nearly normal. 
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Rothe and Selkurt,^ using the same criteria for irreversible 
shock, found that despite repeated transfusions the central 
4 
venous pressures of their shocked dogs fell. They also 
claim to have discovered vasodilator substances in portal 
and arterial blood during the terminal hypotensive phase of 
hemorrhagic shock. Although they concede the presence of 
terminal cardiac failure, they ascribe the cause of irrevers¬ 
ible shock to peripheral failure with decreased cardiac fil¬ 
ling, 
Frank et al,^ took another approach and found that 
after bleeding dogs to a mean arterial blood pressure of 
thirty millimeters mercury they could prevent the death of 
the dogs by perfusing the hepatic circulatory system at a 
normal pressure. Perfusing just the jugular veins did not 
increase survival and so they concluded that liver damage 
is the cause of irreversible shock. Exactly how liver dam¬ 
age results in irreversible shock is not clear from their 
work, but they do claim that hepectomized dogs resemble dogs 
in hemorrhagic shock. They note that in early phases of 
shock serum non-protein nitrogen (mostly amino acids) is 
elevated, blood fibrinogen and prothrombin are reduced and 
plasma protein regeneration is impaired. All of these 
observations are indications of decreased liver function. 
Furthermore, the rate of survival was found to be inversely 
proportional to the rate of amino acid rise in the serum. 
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8 Lillehei et al., by concentrating on the intestines, 
have developed yet another theory to explain the patho-phys- 
iology of hemorrhagic shock. They claim that selective per¬ 
fusion of neither the liver nor any other body section except 
the mesenteric circulatory system will prevent irreversible 
shock. Dogs were bled to a mean arterial pressure of thirty- 
five millimeters mercury and maintained at this pressure 
until spontaneous auto-transfusion began. Then all remaining 
shed blood was returned by the authors. During the initial 
hypotensive period the flow to the gut was found to be 
reduced by ninety per cent, more than any other organ. The 
period of auto-transfusion was marked by a change from 
intense mesenteric vasoconstriction to vasodilitation and 
pooling of blood in the mesenteric capillary beds. In the 
post-transfusion (irreversible) phase, there was increased 
pooling of blood in the mesentery with congestion of small 
bowel mucosa and bloody diarrhea. The authors claim that 
occlusion of the superior mesenteric artery in normal dogs 
for three hours will duplicate the picture of reversible 
shock while occlusion for four to five hours will re-create 
irreversible shock. They propose that the prolonged life 
of post-capillary sphincters as compared to pre-capillary 
sphincters enables the fatal pooling of blood in the gut to 
occur. The role of gut bacteria and endotoxins is ruled 
out by the observation that pre-sterilization of the gastro- 
1 > 
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intestinal tract does not help. Irreversible shock is 
believed to be related to the inherent properties of the 
mesenteric vessels. 
9 Schweinberg et al.' also concentrated on the role of 
intestinal damage during hemorrhagic shock and also noted 
swollen hemorrhagic mucosa and bloody diarrhea, but 
ascribed these lesions to damage created by bacterial endo¬ 
toxins and not shock per se. Dogs pre-treated with non¬ 
absorbable antibiotics, polymixin B or bacitracin, were 
able to survive longer in shock and did not spontaneously 
auto-transfuse even after six hours. Blood or plasma taken 
from dogs and rabbits during irreversible shock produced no 
harmful effects in normal dogs and rabbits but when given 
to animals during the stage of reversible shock (early hemor¬ 
rhagic shock), bloody diarrhea and early death occurred. 
Since the infused plasma was found to be sterile, the authors 
concluded that an endotoxin derived from endogenous gut 
bacteria produces irreversible shock because of the inability 
of animals to detoxify the endotoxin during early hemorrhagic 
shock. Jacob et al»^° found that pre-treatment of dogs with 
either aureomycin, neomycin, terramycin or penicillin 
(orally or parenterally) increased per cent survival from 
twenty to fifty per cent. Clostridia and various intestinal 
aerobes were found in twenty-five per cent of shock tissues 
and blood cultures. Since they found that virtual elimina¬ 
tion of all intra-intestinal flora alone did not affect 
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survival but systemic antibiotic coverage did, these authors 
attributed success with antibiotic therapy to the elimina¬ 
tion of bacteria within tissues during shock. 
Another logical organ to study in relation to irre¬ 
versible shock is the heart. For, if the pump fails, then 
changes in the rest of the circulatory system become extran¬ 
eous in determining the final outcome. Many researchers 
have taken the approach that cardiac failure preceeds or at 
least contributes to circulatory failure during hemorrhagic 
shock, 
Crowell and Guyton‘Sbled fifty-five dogs to a 
mean arterial blood pressure of thirty millimeters mercury 
and kept the dogs at this pressure until the stage of irre¬ 
versibility (which they defined as the period in which the 
dogs began to auto-transfuse). They founds a) no change 
in oxygen consumption, b) no change in peripheral resist¬ 
ance if hematocrit and blood pressure were kept constant, 
c) suddenly increased left atrial pressure and then increased 
right atrial pressure. The requirement of increased atrial 
(or venous) pressure to maintain cardiac output is character¬ 
istic of heart failure. The authors propose that in early 
hemorrhagic shock no blood infusion is needed to maintain 
the low arterial pressures characteristic of this stage, 
and the heart is not in failure, At the stage of auto¬ 
transfusion, increased blood volume is needed to maintain 
arterial blood pressure as the heart is in early failure. 
: 
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Finally, in later stages, the failure becomes severe and no 
amount of blood infusion can enable the heart to maintain 
an adequate arterial pressure. Wiggers J too found that in 
late hemorrhagic shock cardiac output could only be main¬ 
tained at the expense of elevated central venous pressures. 
14 Sarnoff et al. discovered that the increase m left 
atrial pressure could be prevented by increased flow through 
the left main coronary artery and concluded that insuffi¬ 
cient left coronary flow is responsible for the deteriora¬ 
tion occurring during late hemorrhagic shock. Albert et 
al.1^ bled dogs to a mean arterial blood pressure of thirty 
millimeters mercury and found increased survival following 
a period of hypotension and low cardiac output (500 cc/min.) 
if the coronary arteries were selectively perfused. 
Glaviano and Klovda1^ ascribe decreased cardiac performance 
in late hemorrhagic shock to depletion of norepinephrine 
stores in the sympathetic nerve endings in the heart 
secondary to constant sympathetic stimulation, A gradual 
decrease in systolic and diastolic blood pressures, left 
ventricular pressure and force of contraction in response 
17 to stellate ganglion stimulation was noted. Lefer et al. ' 
have characterized a "mycardial depressant factor” in 
hemorrhagic shock. Plasma taken from cats in hemorrhagic 
shock showed a decreasing inotropic effect on isolated 
papillary muscle contractility. There was virtually a 
linear relationship between the concentration of shock 
■ 
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dialysate and the magnitude of diminished muscle contrac¬ 
tility, Further studies revealed the factor to be a small 
dialyzable peptide of molecular weight eight hundred to one 
thousand (believed to be too small to'be an endotoxin). 
The concentration of this factor in serum is proportional 
to the length of time the animal is hypotensive. LeferXv' 
was able to demonstrate : that in dogs bled to a mean arter¬ 
ial blood pressure of forty millimeters mercury until twenty 
per cent of shed blood was auto-transfused, dialysis 
resulted in increased cardiac output, decreased myocardial 
depressant factor in the blood stream and increased survival. 
The author’s hypothesis is that hypotensive ischemia results 
in decreased splanchnic circulation with disruption of pan¬ 
creatic lysosomes and subsequent release of lysozymes and 
proteases. These substances then supposedly act on certain 
plasma proteins to release myocardial depressant factor. 
The author has shown that pancreatectomy and glucocorticoids 
both fend to lower circulating depressant factor while pan¬ 
creatitis in non-shocked dogs causes a small increase. 
Although no definitive mechanism for the deterioration 
seen in hemorrhagic shock has yet been discovered, if is 
apparent that the heart is affected. Whether directly 
affected by shock per se or secondarily by circulatory 
changes or other factors, the heart is involved to a signi¬ 
ficant extent in the homeostatic defenses during hemorrhagic 
• . 
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shocks The reaction of this organ to the stresses of hemor¬ 
rhage have been extensively studied by many investigators. 
19 ... Horvath et al. have examined cardiac dynamics and 
coronary blood flow during shock conditions. As dogs had 
four per cent of their blood volumes removed within fif¬ 
teen minutes, their mean arterial pressures fell from one 
hundred and twenty-seven to thirty-five millimeters of 
mercury. Cardiac output fell from 2.6 liters per minute 
to 0.2 liters per minute and coronary vascular resistance 
decreased from 1,51 to 0.74, resulting in a net decrease 
of coronary blood flow from eighty-five to forty-eight 
milliliters per one hundred grams left ventricle per minute. 
Left ventricular oxygen consumption fell (7.1 milliliters 
per minute to 4.2 milliliters per minute) but so too did 
left ventricular work (4,6 kilogram-meters per minute to 
0.8 kilogram-meters per minute). At the same time, left 
ventricular oxygen extraction increased and coronary sinus 
oxygen content decreased. The authors conclude that dogs 
in shock are able to compensate for reduced coronary blood 
flow by increased myocardial oxygen extraction and decreased 
. 20 
cardiac work. Opdyke and Foreman measured coronary blood 
flow following re-infusion of lost blood. They noted up to 
four times the normal blood flow immediately following 
transfusion and then a gradual return to normal as coronary 
artery resistance increased. They believe that there is 
maximal coronary artery vasodilitation during shock and that 
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any decrease in coronary blood flow is due solely to 
21 decreased blood pressure. Ratliff et al. dispute this 
finding. Using hyperbaric oxygen, they discovered an 
inverse relationship between myocardial blood flow and 
arterial oxygen content in normal dogs. Dogs in shock 
were found not to have a further reduction in coronary 
blood flow after the administration of hyperbaric oxygen, 
but upon going from hyperbaric oxygen to room air the 
coronary blood flow increased. Thus they conclude that 
myocardial blood flow in shock is an active process, 
22 
responding to complex control mechanisms. Bing and Ramos 
studied the net effect of all these myocardial oxygenation 
mechanisms by measuring the difference in redox potential 
between arterial and coronary sinus blood. With a decrease 
in oxygen, various substances become chemically reduced 
(DPN to DPN H+, pyruvate to lactate, etc.) and this forms 
the basis for changes in redox potential. The difference 
in redox potential between arterial and coronary sinus blood 
is normally positive, indicating aerobic metabolism. During 
oligemic shock these authors found the net redox potential 
to become even more positive and to fall during irreversible 
shock but still never become negative. They conclude that 
there is no myocardial anoxia during oligemic shock and 
that prevention of anoxia may be due to the intense coronary 
artery vasodilitation occurring during shock. 
• • • '••••..' . • . •' ■ 
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2 3 Goodyer examined the hemodynamics of the heart during 
hemorrhagic shock in dogs at a mean arterial blood pressure 
of forty to fifty millimeters mercury and an oxygen debt of 
one hundred and forty milliliters per kilogram. He found 
that the contractile capacity of the myocardium was well 
maintained or even augmented during the first three hours 
24 
of shock. Siegel and Downing, however, noted a decrease 
in both stroke volume and dP/dt during the first two hours 
of shock in cats at a mean arterial blood pressure of thirty 
plus or minus five millimeters mercury. Re-infusion of 
blood at this point did not increase either stroke volume 
or dP/dt significantly and primarily led to an increased 
left ventricular end-diastolic pressure, indicating heart 
2 3 failure, Gomez and Hamilton v studied left ventricular con¬ 
tractility by observing how well dog hearts could handle an 
infusion of blood into the left atrial appendage. In normal 
dogs, there is an immediate Increase in cardiac output, 
increased aortic flow (up to three times the rate of infu¬ 
sion), and a return of left atrial pressure to normal. In 
dogs bled to a blood pressure of thirty millimeters mercury 
for ninety minutes and then re-infused to normal pressure, 
the same manipulation resulted in a normal response Initially 
but after being normotensive for one hundred and fifty 
minutes there was a marked increase in left atrial pressure 
while cardiac output remained constant or decreased. The 
authors concluded that some damage is done to animals in 

12 
shock during the hypotensive period which eventually results 
in decreased myocardial function. Maintaining coronary 
artery pressure at normal levels during a period of general- 
2 ized hypotension did not prevent this deterioration. Gauer 
has described an interesting observation which he feels may 
account for some myocardial damage during hemorrhagic shock. 
Normally, the peak left ventricular and aortic pressures 
are confluent. However, in hemorrhagic shock, while the 
peak aortic pressure is fifty to sixty millimeters mercury, 
the peak left ventricular pressure is one hundred and twenty 
to two hundred millimeters mercury. He concluded that the 
ventricle is continuing to contract isometrically with con¬ 
siderable force even after its small volume of blood has 
been expelled. 
There is ample evidence of anatomical damage in hearts 
2? 
subjected to hemorrhagic shock. Melcher and Walcott found 
infiltration of myocardial fibers and actual necrosos of 
fibers with an accompanying inflammatory reaction follow¬ 
ing various types of shock in twenty-two out of twenty-nine 
dogs. The lesions were primarily below the subendocardial 
surface of the heart and in the papillary muscles. Martin 
28 
and Hackel bled dogs to a blood pressure of thirty-four 
millimeters mercury and watched them for two and a half 
hours before re-infusion. They periodically sacrificed a 
dog to examine the myocardium. Grossly, there were subendo¬ 
cardial hemorrhages in fourteen out of sixteen dogs that 
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died or were sacrificed within five days after the shock pro¬ 
cedure, Microscopically, there were zonal lesions, described 
as swollen bands of altered sarcoplasm within the myofibers 
near intercalated discs, in the subendocardium and papillary 
muscles in seventeen out of twenty dogs examined as soon as 
fifteen minutes after shock and up to five weeks after shock. 
No zonal lesions were seen after five weeks post shock. The 
zonal lesions were characterized histochemically by depletion 
of succinic dehydrogenase and cytochrome oxidase activity 
with adjacent bands of increased enzyme activity. In addition, 
there were segmented lesions consisting of isolated single 
cells or groups of cells with coarse granules which stained 
deeply for succinic dehydrogenase and cytochrome oxidase. 
Segmental lesions were only seen from nine to forty-eight hours 
after shock. Finally, advanced lesions of necrotic myofibers 
plus inflammatory reactions were seen In eight of ten dogs 
that survived more than fourteen hours following shock. The 
authors believe that the zonal lesions, appearing very shortly 
after shock represent reversible early metabolic disruption 
of the myocardial cell, that segmental lesions represent early- 
cell necrosis and advanced lesions signify an area of extended 
. 29 
necrosis. In another study, Martin and Hackel used the 
electron microscope to further examine these lesions in dogs 
bled to thirty-five millimeters mercury for only one hour. 
Under the electron microscope, zonal lesions were marked by 
hypercontraction with fragmentation of myofibrils and 
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displacement of mitochondria. All of these lesions affected 
only a portion of the myocyte (near the intercalated disc). 
Their appearance within four to eight days was accompanied by 
relaxation of the hyper-contraction. Areas of necrosis were 
seen only after six hours and were gone by two to three weeks. 
The authors could not determine whether areas of necrosis 
were derived from severe zonal lesions, 
Martin et al„^° viewed the contractions of the heart 
during hemorrhagic shock via cineangiocardiography, They 
observed* a) a marked decrease in end-diastolic and end- 
systolic volumes one hour after shock, b) obliteration of the 
apical portion of the left ventricular cavity during systole 
and c) prolonged isometric contraction. Measuring intra¬ 
ventricular pressures, they recorded a pressure gradient of 
one hundred and fifty to three hundred millimeters mercury 
between the apical and basal portions of the left ventricle. 
Their conclusion was that physical damage to the myocardium 
may be a result of abnormal contraction during shock, Hackel 
31 
et al, extended this theory by examining the lesions of 
dog hearts that were subjected to heart block during hemor¬ 
rhagic shock so that the heart rate never exceeded thirty 
to forty beats per minute. They noted a decrease in both 
zonal lesions and subendocardial hemorrhage, Ratlif et al.J£ 
attempted to elucidate the role of hypoxia in the production 
of these lesions. They subjected dogs to hyperbaric oxygen 
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during hemorrhagic shock and found significantly less suben¬ 
docardial hemorrhage (the hemorrhagic lesions were inversely 
proportional to venous pC^) but no change in the frequency of 
zonal lesions. Their conclusion therefore was that hypoxia 
is responsible for subendocardial hemorrhage and necrosis 
while zonal lesions are due to other causes (i.e, severe 
hyper-contraction). 
In order to understand the subtle (and perhaps earliest) 
myocardial derangements during hemorrhagic shock, one must 
understand the metabolic pathways for energy production norm¬ 
ally available to myocardial cells and relate them to altera- 
33 34 
tions produced by shock, Bing^'" has found the myocardium 
to be amazingly versatile in its ability to utilize various 
substrates for energy production. Glucose, pyruvate, lactate, 
fatty acids, amino acids, and ketones are all used under nor¬ 
mal conditions In the following ratios glucose 17.9$. pyru¬ 
vate 0,5476, lactate 16,476 (total carbohydrates 3^*9$)* fatty 
acids 6776, amino acids 5,676, and ketones 4,376 (total non¬ 
carbohydrates 76,976), The rate of utilization of the indi¬ 
vidual carbohydrates was found to be a function of their 
arterial concentration and not related to cardiac work, 
33 Goodale and Hackel^ found the coefficient of extraction 
(arteriovenous difference divided by arterial concentration) 
to be approximately equal for lactate and pyruvate. Thus, 
the low arterial concentration of pyruvate accounts for its 
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small contribution to energy production. While lactate and 
pyruvate can be extracted from the arterial system at very 
low concentrations, a minimum concentration of glucose 
(5^.2 mg%) is required. The extractions of glucose, pyru¬ 
vate and lactate were found to be independent of each other 
and proportional only to their arterial concentrations. The 
extraction coefficients appeared not only to be unaffected 
by cardiac work, but also by coronary artery blood flow. 
They calculated total carbohydrate utilization under normal 
conditions to be as high as sixty-six per cent (based on a 
respiratory quotient of 0.91). At very high concentrations, 
glucose and pyruvate extraction alone could account for over 
one hundred per cent of oxygen extraction if totally oxidized. 
Therefore at high concentrations, some glucose must be stored 
as glycogen. In later studies Bing et al.J suggested that 
glucose and lactate compete as sources of energy and that an 
increase in the arterial concentration of one may decrease 
the extraction of the other. 
Although arterial concentration may be the primary deter 
minant of carbohydrate utilization, competition, particularly 
between carbohydrates and fatty acids, for either extraction 
or utilization also plays a role, Shipp et al. labeled 
palmitate (a fatty acid) with and noted that when fatty 
acids are the only substrate available, they are readily 
removed from the arterial system and approximately fifty per 
cent is converted to carbon dioxide, the rest to tissue 
lipids. The addition of glucose into the arterial system had 

17 
no effect on fatty acid uptake nor conversion to carbon 
dioxide. However, when the fate of radioactive glucose was 
followed with non-radioactive fatty acids present, glucose 
uptake was slightly decreased, glucose oxidation to carbon 
dioxide was markedly reduced and radioactive glycogen stores 
were increased. The same observations were made by Bowman.-5 
The conclusions reached were that the heart preferentially 
39 40 
utilizes fatty acids as an energy substrate. Evans et al. 
studied the interrelationship of pyruvate and fatty acids. 
Using labeled pyruvate they found that pyruvate uptake is 
increased as the arterial concentration of pyruvate increases, 
but the per cent of available pyruvate that was extracted 
decreased as concentrations became higher. At each concentra¬ 
tion, approximately sixty per cent of the extracted pyruvate 
was converted to carbon dioxide. At a concentration of five 
to ten millimoles per liter, pyruvate could account for 
total carbon dioxide production. The addition of palmitate 
decreased pyruvate extraction and decreased its oxidation 
to carbon dioxide even more. The decarboxylation of pyruvate 
decreased in proportion to the fatty acid concentration 
while total carbon dioxide production remained the same. At 
high concentrations (five to ten millimoles per liter) 
pyruvate did not decrease the uptake of radioactive palmitate 
but did cause a decrease in the quantity recovered as 
labeled carbon dioxide and an increase in the amount of 
41 
labeled tissue lipids, Krasnow et al. ' found a decreased 
. 
. 
' ... ; c.A- . . .cl 
, n .C-'5 
for ';/ 
18 
lactate uptake during conditions favoring intracellular 
glycolysis or increased free fatty acid uptake such as mild 
tachycardia, moderate hypoxia and anemia. 
42 Neely et al. have done an extensive review of the 
intermediary metabolic pathways and metabolic controls of 
the heart. They found that in the absence of insulin 
(required for facilitated glucose transport across the cell 
membrane) glucose uptake is decreased and the rate of glu¬ 
cose transport into the myocardial cell is the limiting 
factor in its utilization as an energy source. In the 
presence of insulin, glucose uptake is increased by cardiac 
work (contrary to the experience of Bing)^ and decreased 
by ketones and fatty acids. Fatty acids, however, do not 
inhibit glucose uptake in anaerobic hearts, suggesting that 
they must be metabolized before they can exert an inhibitory 
effect. Free glucose must be converted to glucose-6-phos- 
phate before it can be further metabolized. The enzyme, 
hexokinase, which performs this function is Inhibited by 
glucose-4-phosphate, thus forming a feed-back regulatory 
loop, Glueose-6-phosphate can go into glycogen storage, 
the glycolytic pathway or the pentose-phosphate shunt. Con¬ 
version of fructose-6-phosphate to fructose-1,6-diphosphate 
by phosphofructokinase is the first irreversible step in the 
glycolytic pathway (glucose-6-phosphate to fructose-6-fruc- 
tose-6-phosphate is reversible), Phosphofructokinase is 
inhibited by ATP and citrate, and enhanced by free phosphate, 
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19 
5'AMP, ADP and cyclic AMP. Pyruvate dehydrogenase which 
converts pyruvate (the end product of the glycolytic path- 
way) to acetyl-GoA is the next major regulatory enzyme and 
is the common link for the aerobic utilization of all car¬ 
bohydrate substrates. This enzyme is inhibited by ATP, 
NADH, and acetyl-GoA. Its activity is enhanced by NAD. In 
addition to allosteric control, pyruvate dehydrogenase is 
controlled by phosphorylation (inactive) and dephosphoryla¬ 
tion (active) mechanisms similar to those involved in glyco¬ 
gen storage. The preferential use of fatty acids in normal 
myocardial metabolism involves inhibition of hexokinase, 
phosphofructokinase and pyruvate dehydrogenase via acetyl- 
CoA, NADH, ATP and citrate accumulations plus stimulation 
of glycogen synthetase and inhibition of glycogen phosphory- 
lase which are involved in glycogen storage pathways. 
The rate of free fatty acid uptake by the heart is 
proportional to the serum concentration, but levels off at 
very high concentrations. Increased albumin concentration 
and reduced oxygen supply will inhibit uptake. Utilization 
of fatty acids is primarily determined by conversion of 
acyl-CoA to acetyl-GoA via beta oxidation. Beta oxidation 
is inhibited by accumulation of acetyl-GoA and decreased 
oxidative phosphorylation. Another limitation to the utili¬ 
zation of fatty acids is due to the prevention of transloca¬ 
tion across the inner mitochondrial membrane of acyl-carnitine 
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units which occurs with increased cardiac work either because 
of reduced availability of free CoASH (used also in the 
succinic dehydrogenase reaction of the TCA cycle) or decreased 
formation of transferase II. 
The TCA cycle is regulated by ATP/ADP and NABH/NAD 
ratios (increases as the ratio decreases) plus the actions 
of certain regulatory enzymes. Citrate synthetase activity 
depends on the availability of aeetyl-G©A and oxaloacetate 
and is inhibited by free CoASH and succinyl-GoA. NAD speci¬ 
fic isocitrate dehydrogenase is activated by ADP and inhib¬ 
ited by NADH and ATP, Finally, alpha-ketoglutarate dehydro¬ 
genase is inhibited by succinyl-CoA and NADH, 
We can now turn to what is known of myocardial metabo¬ 
lism during hemorrhagic shock and see how it compares with 
. . . . 43 
metabolism under normal conditions. Spitzer and Spitzer 
used labeled free fatty acids during early hemorrhagic 
shock (prior to anaerobic metabolism) to determine the rela¬ 
tive utilization of fatty acids versus carbohydrates. In 
control dogs there was considerable fatty acid and lactate 
extraction plus glucose extraction in less than half. Myo¬ 
cardial carbon dioxide production was two-thirds free fatty 
acid and approximately one-third lactate derived. During 
early hemorrhagic shock, free fatty acid extraction decreased, 
lactate extraction remained at its normally high level and 
glucose extraction was found in all dogs. Myocardial carbon 
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dioxide production shifted to only one fifth derived from 
fatty acids and approximately two thirds from lactate. Thus 
in early hemorrhagic shock, dog myocardiums rely more on 
carbohydrate metabolism than fatty acid metabolism, Addi- 
44 
tionally, Doersching and Glaviano found that although the 
total concentration of phosphorylase remained constant 
during shock, the activity of phosphorylase a (which leads to 
increased glycogen production) is increased. The actual con¬ 
centration of glycogen within the myocardium was also meas¬ 
ured and found to be increased. Hence significant glycoly¬ 
sis is not present during hemorrhagic shock as a source of 
energy substrates. This leaves exogenous carbohydrates as 
the major energy source during hemorrhagic shock, 
. 45 According to Hackel and Goodale ' arterial pyruvate 
concentration increases during hemorrhagic shock but the 
arterio-venous difference does not increase and eventually 
becomes negative. Hence, impaired pyruvate metabolism is 
implied. Arterial lactate concentration increases and the 
arteriovenous difference becomes slightly more positive. 
However, the increase in uptake is less than the increase 
in arterial concentration so that the coefficient of extrac¬ 
tion decreases. Arterial glucose concentration also increases 
but glucose extraction remains constant and eventually 
decreases (never becomes negative). Despite the low blood 
pressure and cardiac output, coronary flow did not appear 
to decrease. Due to tachycardia and increased myocardial 
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oxygen extraction (from sixty-four to eighty-five per cent) 
total utilization of oxygen by the myocardium remained normal. 
The authors found the negligible or negative pyruvate extrac¬ 
tion to be the most consistent and striking abnormality in 
hemorrhagic shock. The effect of high arterial lactate con¬ 
centration in diminishing the uptake of pyruvate was disproved 
by infusing lactate into normal dogs and noting no change in 
46 pyruvate extraction. Burdette found a high pyruvate content 
in cardiac muscle cells in hemorrhagic shocked dogs and con¬ 
cluded that this may represent a breakdown in the ability of 
carbohydrates to enter the TCA cycle. This was observed in 
early hemorrhagic shock before the presence of lactic acid 
47 production. Marchetti et al. ' observed that pyruvate was 
normally discharged from the myocardiums of unanesthetized 
dogs but that this negative extraction becomes even greater 
during shock. There was no change in myocardial oxygen con¬ 
sumption until the dogs' blood pressures fell below seventy 
to eighty millimeters mercury (when it fell to fifty-seven 
per cent of normal). However, at this point the cardiac 
work fell to ten per cent of normal. The redox potential 
across the heart remained positive and there was no excess 
lactate. The authors suggest that myocardial damage during 
early shock is represented by the increased pyruvate dis¬ 
charge and that this is not due to hypoxia but may be the 
result of excessive catecholamines or peripheral factors, 
Burdette et al,^*^ noted that oxygen consumption decreased 
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after four hours in rats kept in hemorrhagic shock. The 
oxygen consumption could be increased by pyruvate infusions. 
Therefore, they concluded that animals in shock are still 
able to metabolize pyruvate. They noted, however, that the 
increase in oxygen consumption is not as great as that 
found in normal dogs given the same amount of pyruvate. 
Edwards et al,^° ascribe the negative pyruvate extrac¬ 
tion to hypoxic destruction of cocarboxylase (thiamine pyro¬ 
phosphate), the coenzyme needed to convert pyruvate to 
acetyl-CoA. They claim that in hemorrhagic shock the coron¬ 
ary blood flow decreases while the per cent oxygen extrac¬ 
tion remains constant, hence a relative ischemic condition. 
They explain the continued utilization of lactate during 
negative pyruvate extraction (and a presumed block at the 
cocarboxylase level) on either conversion to glycogen via 
glycolysis reversal or direct oxidation via lactic acid oxi¬ 
dase I (requiring only lactate, molecular oxygen and cyto- 
Cl 
chrome c). Hackel and Bretenecker studied the time factor 
in the production of metabolic derangement during hemor¬ 
rhagic shock by comparing dogs bled to thirty-two milli¬ 
meters mercury for three to three and a half hours wiuh 
those in shock for only one to one and a quarter hours. 
The pyruvate extraction became increasingly lower and fin¬ 
ally negative as shock persisted. Transfusions after one 
hour restored normal pyruvate metabolism while after three 
hours it could not. They concluded that progressive 
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ischemia leads to irreversible enzyme changes. Further¬ 
more, the localization of the defect to cocarboxylase was 
reenforced by noting that the myocardial oxygen extraction 
was proportional to the inverse of the coronary blood flow 
which they claim is seen in thiamine (cocarboxylase sub¬ 
strate) deficiency and not in normal dogs. 
McKeever et al. J maintained the circulation of 
the coronary vessels at normal levels while placing dogs 
in hemorrhagic shock and still noted abnormal pyruvate metab¬ 
olism and eventually irreversible shock. Hence, they believe 
myocardial damage can occur during shock despite maintenance 
of adequate coronary flow and oxygen availability. Ratliff 
et al. were able to increase a decreased lactate extraction, 
which they found during hemorrhagic shock, by using oxygen 
at a high pressure in their experiments. They were not able 
to correct pyruvate metabolism or prevent zonal lesions. 
Goodyer et al.^ bled dogs to an aortic pressure of thirty 
to forty millimeters mercury and them a) used an inflat¬ 
able balloon in the aorta to keep coronary blood pressure 
at ninety to one hundred and thirty millimeters mercury, 
b) cross-transfused a shock dog to a normotensive dog and 
c) used a pump between the right atrium and femoral artery 
to sustain systemic pressure at eighty to one hundred and 
twenty-five millimeters mercury while coronary artery pres¬ 
sure remained at thirty to forty millimeters mercury due 
to a ligature around the aorta. The balloon support of 
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coronary artery pressure failed to prevent negative pyruvate 
extraction but could not normalize it. Support of the 
systemic pressure prevented negative pyruvate extraction for 
sixty to seventy minutes. Their conclusion was that the 
abnormal myocardial production of pyruvate is not due simply 
to reduced coronary artery perfusion but is related to a 
peripheral factor which can be partly corrected by maintain¬ 
ing normal systemic blood flow, Landsgaard-Hansen et al,jt>9j/ 
measured the activities of various enzymes, glucose“6-phos¬ 
phate dehydrogenase, pyruvate kinase and lactate dehydro¬ 
genase in different parts of the left ventricle (from the 
apex to base). In normal dogs there was no change in activ¬ 
ity of these enzymes from one position of the ventricle to 
another, but during hemorrhagic shock there were gradients 
of enzyme activity (activity greater in apical regions than 
basal). Gradients were also discovered during myocardial 
hypoxia but they followed a different distribution. Owing 
to the ability of beta-blockers to abolish the abnormal 
shock gradients, they concluded that excessive catecholamine 
activity may be responsible for myocardial damage via exces¬ 
sive contractions. 
The most commonly noted early metabolic derangement 
of hemorrhagic shock is negative myocardial pyruvate extrac¬ 
tion, A likely reason for this would be a metabolic block 
which permitted carbohydrate metabolism to proceed to the 
stage of pyruvate production but prevented subsequent 
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introduction of pyruvate into the TCA cycle. The pyruvate 
dehydrogenase complex is responsible for conversion of 
pyruvate to acetyl-GoA and hence bridges the gap between 
the glycolytic and TCA cycles. The complex consists of 
three enzymes in non-covalent linkage, pyruvate dehydro¬ 
genase, dihydrolipoyl transacetylase, and dihydrolipoyl 
dehydrogenase. Their activity depends on the presence of 
a flavoprotein, thiamine pyrophosphate (cocarboxylase) and 
ro 
NAD as diagramed belowsJ 
A/AD+ 
£_H3cic.oArt 
OH 
(c%cH-TPP) 
Pyuv/cfVie_ 
Ctpp] 
nshs^_iy 
(FAD) 
Di I 
J 
NS-S" / 
(w 6) 4 J 
(U*Stf) t 
DiK^Aro\ipo^\ 
Trows 7^CHjC-C0ft 
(043LsL^)-^CoPiSrt 
NADH Hf 
The complex has a molecular weight of four million and is 
alkaline sensitive. The activity of the complex is regu¬ 
lated by a phosphorylation (inactive) and de“-phosphorylation 
(active) system at the pyruvate dehydrogenase step.^ The 
phosphotase enzyme requires ten times as much magnesium ion 
as the kinase enzyme. Therefore, the activity of the complex 
is greater when the ATP/ADP ratio is low and consequently 
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2? 
more free magnesium is available. The complex is also 
inhibited by acetyl-CoA acting on pyruvate dehydrogenase 
6q 
and NADH acting on the flavoprotein. Fatty acids inhibit 
the complex via; a) acetyl-CoA and NADH production, b) com" 
petition of enzyme systems for CoA and NAD, c) direct 
effect of pyruvate dehydrogenase and d) ATP production. 
Thiamine pyrophosphate, (cocarboxylase), is broken down 
when oxygen is withdrawn in vitro and is split by a phos- 
photase under conditions of anoxia in tissue extracts.0^ 
The following experiments attempt to examine this 
critical step in pyruvate (and carbohydrate) metabolism 
during hemorrhagic shock by determining the effects of 
thiamine on the abnormal myocardial pyruvate extraction 
seen during shock and by assaying the activity of both the 
pyruvate dehydrogenase complex and cocarboxylase in normal 
and shocked dogs. 
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METHODS AND MATERIALS 
Experiment I 
Ten mongrel dogs (21,5 - 43,0 lbs.) were anesthetized 
intravenously with allobarbital ,44 cc/kg (Dial with Ure¬ 
thane, GIBA Pharmaceutical Co.), A number ?F NIH catheter 
(U. S. Catheter and Instrument Co.) was inserted into the 
right external jugular vein. PE 330» 0,14?" 0D polyethy¬ 
lene tubing (Clay Adams) attached to a three-way stopcock 
was used for carmulating the right carotid artery. The left 
femoral artery and vein were cannulated with number 7 cour- 
and catheters (U, S. Catheter and Instrument Co.), All 
catheters were flushed with a solution of 1 cc heparin in 
500 cc normal saline. After catheterization, the dogs were 
intubated and respiration was maintained via a compressed 
air ventilator. 
Under flouroscopy, the right external jugular cathe¬ 
ter was positioned in the coronary sinus. Two cc of blood 
were slowly withdrawn to determine per cent oxygen satura¬ 
tion, Normal venous blood is approximately 60 to 80% oxy¬ 
gen saturated. Coronary sinus blood, due to high myocardial 
oxygen extraction, is normally only 20 to 40% saturated. 
Finding a low per cent saturation in blood obtained from the 
positioned catheter was used as evidence of proper placement. 
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, 
. • 
29 
At autopsy the correct position of the catheter tip was 
again verified. 
The dogs were then heparinized with sodium heparin 
,15 cc/kg intravenously. Arterial blood pressure was meas¬ 
ured and arterial and coronary sinus blood samples were 
drawn prior to placing the dogs in hemorrhagic shock. Blood 
pressure was determined by a transducer connected to the 
femoral artery catheter and a photorecording oscilloscope 
(Electronics for Medicine, White Plains, N. Y.). The trans¬ 
ducer was calibrated at several pressures with a mercury- 
column prior to each experiment. Arterial and coronary 
sinus blood samples were analyzed for hemoglobin content, 
per cent oxygen saturation, pyruvate and lactate concentra¬ 
tions. Before obtaining blood samples, the catheters were 
flushed by withdrawing and discarding ten milliliters of 
blood. 
Oxygen saturation readings were done on 1-2 cc of 
unhemolyzed blood with the Reflection Oximeter (American 
Optical), Hemoglobin content was measured on 20 cu mm 
blood samples with a Fischer Hemophotometer. pH determina¬ 
tions were performed on selected samples with a Model 113 
pH and blood gas analyzing system, employing glass elec¬ 
trodes to measure the potential established between unknown 
and standard reference solutions. 
Lactate and pyruvate assays were performed on a Teco- 
meter (Boehringer Mannheim Corp.) using Teco-meter kits. 
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The assays are based on the reactions 
LDH . 
pyruvate + NADH H+ { ,niz~a? lactate + NAD + 
A surplus of NADH plus LDH will shift the reaction to the 
right while NAD will do the opposite. The amount of shift 
depends upon the concentration of pyruvate in the former 
case and lactate in the latter. Since NADH absorbs light 
at a peak wavelength of 3^0nm and NAD does not absorb between 
3Q0-4Q0nm, optical densities can be used to determine the 
extent of the reactions and thus the substrate concentra¬ 
tions . 
To determine lactate concentration, 4cc of iced 0,6n 
perchloric acid (a protein denaturant) was pipetted into a 
test tube. Both tube and acid were weighed together. A 2cc 
blood sample was added and the tube reweighed to determine 
net blood weight. The solution was then centrifuged at 
3000 rpm for 30 minutes. 0,20ml of supernatant was added to 
a cuvette containing 2.0ml of 0.5M glycine buffer (pH 9,0), 
0.20ml NAD (27raM/?ml)» and 0.02ml LDH (2mg/ml). The optical 
density of this solution was read at 366 nm wavelength. A 
blank was made by adding 2.0ml of Q.5M glycine buffer, 0»2Qml 
perchloric acid (0.6N), 0.20ml NAD (27mM/7ral), and 0.02ml 
LDH (2mg/ml). The difference in optical density between the 
sample and the blank times calibration and weight correction 
factors gives the final lactate concentration in mg/lOOml 
blood. 
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lactate (mg/10Oml)=9^.1 x x (O.D. sample- 
z^biood wt; 0.d. blank) 
For pyruvate determinations, 11ml of 60% perchloric 
solution was added to 89ml of iced distilled water and 
weighed. To this solution (approximately IN perchloric 
acid) an 8ml blood sample was added. The final solution was 
weighed and then centrifuged at 3000 rpm for 30 minutes. 
Four ml of supernatant was mixed with 2,0ml of a Q.7M tri¬ 
potassium phosphate buffer. The buffered sample was kept on 
ice for ten minutes, filtered and then warmed in a 25° centi¬ 
grade bath for one hour. Afterwards, 2,0ml of filtrate was 
combined with 0.2ml of NADH (2,5mM/4ml). The optical density 
of this solution was read at 366 nm wavelength. With the 
addition of 0.02ml of LDH (2mg/ml) the optical density was 
again recorded. The change in optical density multiplied by 
calibration and weight factors gives the pyruvate concentra¬ 
tion in micro-moles/ml blood, 
pyruvate (micro-moles/ml) = x x delta O.D. 
9.2 2xblood wt. 
Hemorrhage was begun by attaching a glass bottle and a 
50 cc heparinized syringe to the three-way stopcock on the 
carotid artery cannula. The dogs were bled by letting their 
blood flow freely into the glass bottle until the mean arter¬ 
ial pressure was between 30~^0mm Hg, Bleeding time averaged 
approximately five minutes. Periodically, blood was either 
withdrawn or injected via the 50cc syringe in order to main¬ 
tain a constant blood pressure. 
During shock, the following procedures were followed? 
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In all cases, arterial and coronary sinus samples were 
taken before shock, one hour after induction of shock and 
30 minutes after re-infusion of shed blood. Blood pressures 
were continuously monitored. Thiamine hydrochloride, cocar¬ 
boxylase and sodium bicarbonate were injected into the left 
femoral vein, Dextran in normal saline was administered 
directly into the right carotid artery. 
Experiment II 
Fourteen mongrel dogs (29,0 - 44 lbs) were anesthetized 
with thiamylal (Surital, Park Davis), lcc/51bs,, intraven¬ 
ously. Seven were cannulated and shocked as in experiment I. 
Arterial and coronary sinus blood samples were analyzed for 
pyruvate, lactate and per cent oxygen saturation just before 
and one hour after shock. After obtaining the second blood 
sample, a surgical non-traumatic clamp was placed across the 
heart and apical and basal left ventricular tissue samples 
(approximately one gram each) were removed from the left 
ventricle. The samples were assayed for pyruvate dehydro¬ 
genase and cocarboxylase activity. Seven dogs served as 
controls. They were cannulated and intubated similarly t© 
the shock dogs. Arterial and coronary sinus blood samples 
were obtained and then a small piece of left ventricle apex 
was removed. Bleeding was prevented by keeping a surgical 
non-traumatic clamp across the heart. The dogs were kept 
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on a respirator for one hour. Then a small basal piece of 
left ventricle was removed. 
The pyruvate dehydrogenase assay was based on the work 
62 63 
of Gubler and Cooper. ^ As pyruvate is chemically oxidized 
to acetyl-CoA via a complex series of enzymatic steps, pyru¬ 
vate loses one carbon dioxide molecule and one hydrogen ion. 
The oxidation of pyruvate can be coupled with the reduction 
of ferric cyanide to ferrous cyanide by providing ferric 
cyanide as a reactant instead of GoASH. The change from the 
ferric to ferrous form of iron can be detected by a decrease 
in optical density at 420 mu wavelength. Thus the activity 
of the pyruvate dehydrogenase complex can be monitored. By 
adding cocarboxylase to one cuvette, any decrease in activity 
due to lack of this coenzyrae could also be determined. 
Assay solutions were made by a combination of the fol¬ 
lowing chemicalsj 
Potassium phosphate (Imole/liter) (Fisher) ,20ml 
Magnesium chloride (Imole/liter) (Fisher) ,02ml 
Sodium pyruvate (Imole/liter) (K & K Lab.) ,08ml 
Sodium malate (0,5mole/liter) (K & K Lab.) ,02ml 
Thiamine pyrophosphate (.00217mole/liter) 
Cocarboxylase (Cal Biochem,) ,05ml 
Nicotinamide adenine diphosphate (.Olmole/liter) 
(K & K Lab.) ,12ml 
Adenoside tri-phosphate (.Olmole/liter) 
(K & K Lab., P & L Biochem., Worthington) ,80ml 
Distilled Water 1,05ml 
Solution one contained everything except sodium pyruvate and 
sodium malate as a control. Solution two contained every¬ 
thing except thiamine pyrophosphate (cocarboxylase) in order 
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to determine cocarboxylase activity. Solution three con¬ 
tained all ingredients and served as an assay for pyruvate 
dehydrogenase activity. 
0,5 grams of tissue were added to 4,5ml of .32M sucrose 
(maintaining a Is 9 ratio). The tissue solution was homo¬ 
genized in a Tri-R Stir-R ground glass homogenizer (Model 
R4l, Rockville Center, N, Y.) until there were no lumps 
remaining (approximately five minutes). The homogenized 
solution was centrifuged at 1600 rpm for 15 minutes to remove 
nuclear debris. The supernatant was poured into a fresh 
test tube kept in an ice bucket, 
A Beckman DU spectrophotometer set at 420 mu was used 
to record optical densities. All readings were taken with 
solutions at room temperature. Originally solution one plus 
0,5ml of homogenate supernatant was used to zero the machine. 
However, the addition of 3*6ml of sodium ferricyanide 
.Olmole/liter (Fisher), which is needed to start the reac¬ 
tion, would cause readings to begin in optical density 
ranges which resulted in either the absorbancy needle going 
off scale during the 20 minute reaction period or produce 
absorbancy readings in an area of the scale which was too 
grossly calibrated to provide accurate readings. Therefore, 
the homogenate supernatant and ferricyanide were added to 
all three solutions at the same time and the machine was 
zeroed so that total solution number one fell at an absorb¬ 
ancy of 0.800 by adjusting the light slit. To reduce any 
O ifuLas 
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major differences in turbidity due to the dense homogenate, 
all cuvettes were read through the frosted side (as per 
Gubler and Cooper), Since all three total solutions were 
originally of approximately the same optical density, all 
three total solutions were found to begin at approximately 
0.800 absorbancy. Immediately after the machine was zeroed, 
the optical densities of total solutions one, two, and 
three were read and subsequently recorded every minute 
thereafter for 20 minutes. 
The control solution (number one) changed slightly 
in optical density over the 20 minute reaction period. This 
is probably due to some endogenous substrate or reducing 
agents contained within the homogenate supernatant. 
The changes in absorbancy per minute for all three 
solutions were calculated and the control changes were 
subtracted from each of the experimental samples. The net 
absorbancy changes were plotted on graph paper and the 
slope, delta A/20 minutes, was determined. Except for early 
erratic recordings (probably due to endogenous oxidizing 
and reducing agents) and a final tapering (probably due to 
exhaustion of substrate) a linear relationship between 
absorbancy and time was noted. Unfortunately, the activity 
of the control samples was so great that only a few readings 
could be taken before the absorbancy needle went off scale 
(even when starting at .8Q0A). A sample of the homogenate 
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supernatant was sent to the Yale-New Haven Hospital Clinical 
Laboratories for nitrogen content analysis. The final enzyme 
and coenzyme activity was expressed as deltaA/20minutes/mg 
nitrogen. 
Experiment III 
Twenty dogs (28-45 lbs,) were anesthetized as per 
experiment II. Ten dogs were put into hemorrhagic shock 
as described previously. Apical and basal left ventricular 
samples were obtained for pyruvate dehydrogenase activity- 
determinations. Arterial and coronary sinus blood samples 
were obtained before and after one hour of shock and then 
assayed for pyruvate, lactate and per cent oxygen satura¬ 
tion, Ten dogs served as controls. Apical and basal left 
ventricular samples were obtained only after one hour on a 
respirator. Blood samples were drawn before and after one 
hour on the respirator. 
Three major changes in the assay procedure were 
employed s 
a) A Beckman DBG model spectrophotometer was used. 
This machine automatically, zeroes samples of different opti¬ 
cal densities and records only the net differences In opti¬ 
cal density between two samples after zero time (i.e. while 
the reaction is progressing). The total assay solutions 
minus ferricyanide (which starts the reaction) were used to 
zero the machine. 
. . • 
, ■ 
'it 
41 
b) After zeroing the machine, ferricyanide was injected 
by using tuberculin syringes. This enabled all reactions to 
begin virtually simultaneously. 
c) Only 0,1ml of homogenate supernatant was used. 
This decreased the original turbidity enough so that the 
clear sides of the cuvettes could be employed and also per¬ 
mitted full 20 minute observations of control enzyme activ¬ 
ity without going off scale. 
Net changes in optical density were read from the 
spectrophotometer each minute for 20 minutes. The plot of 
absorbancy versus time was similar to previous graphs. It 
was discovered that the most consistently linear portion of 
the graph was between five and ten minutes. This region 
represents the period after extraneous reducing agents have 
reacted and before the substrates begin to be critically 
used up. 
All samples were assayed in triplicate and the final 
enzyme activity was recorded as delta A/5 minutes/mg nitrogen. 
, 
': 
■ 
r . 
- 
. 
42 
RESULTS 
Certain generalizations can be made of all dogs placed 
into hemorrhagic shock. Initial mean arterial blood pres- 
sures ranged from 75-150 millimeters mercury (depending to 
some extent on the level of anesthesia). Approximately 
600cc of blood were removed from most dogs, dropping the 
blood pressures to a range of 25-45 millimeters mercury. 
At first, the blood pressures tended to return towards nor¬ 
mal due to intense vasoconstriction. After 30 minutes and 
slightly more hemorrhage, the blood pressures stabilized 
at shock levels. Occasionally, small (25~50cc) infusions 
of shed blood were required to maintain a steady blood pres¬ 
sure. Coronary sinus oxygen saturation was originally- 
found to lie between 25-50 per cent. During shock it fell 
by approximately 20-50 per cent in most cases (see Appendix), 
Experiment I (See Table 1) 
Out of a series of ten dogs, eight showed a change 
from positive to negative myocardial pyruvate extraction 
after one hour of hemorrhagic shock. In the two cases that 
did not show this change, if is noteworthy that the arter¬ 
ial lactate concentrations did not increase as one would 
expect in shock. Therefore, it may be that these dogs did 
not go info the same degree of shock as the other dogs, 
despite similar blood loss. At the same time that the eight 
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dogs began discharging pyruvate, all but one maintained a 
positive lactate arteriovenous difference. 
When blood was re-infused to five of the eight shocked 
dogs with negative pyruvate extractions, two showed a return 
to normal (positive) pyruvate extraction within 30 minutes. 
The shock blood pressures of the five dogs were all similar 
but the amount of time spent in shock was slightly less for 
the two dogs returning to normal (approximately three hours 
versus three and one half to four hours). 
A total of one gram of thiamine hydrochloride was 
given to three shock dogs with negative pyruvate extractions. 
In one case 44,6 millequivalents of sodium bicarbonate was 
also given to neutralize the acidic pH caused by shock. 
Observations lasting from 30 to 90 minutes revealed no 
change in the abnormal pyruvate extraction except for two 
separate single observations which reverted back to abnor¬ 
mality by the next observation. 
One dog given two grams of cocarboxylase and one 
given seven grams both showed persistent negative pyruvate 
extraction. Since cocarboxylase is the active form of 
thiamine in the body (thiamine pyrophosphate), its failure 
to correct the abnormal pyruvate extraction is further evi¬ 
dence of the inability of thiamine administration to signi¬ 
ficantly improve the abnormal pyruvate metabolism. 
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Six per cent dextran in normal saline was given in 
order to restore blood pressure (and intravascular volume) 
to three dogs with negative pyruvate extraction. With the 
dextran, blood pressures returned to within 25 millimeters 
mercury of the original starting blood pressures. Pyruvate 
metabolism became normalized for at least one observation 
in each dog. In two cases, when the dextran was given after 
one hour of shock and then nothing else was done to the dogs, 
negative pyruvate extraction became positive and remained so 
for two hours (except for one negative observation in one of 
them), 
The improvement with dextran did not correlate with 
pH changes. The return to normal pyruvate extraction 
occurred during alkalotic and acidotic conditions. Hemo¬ 
globin concentration and therefore oxygen carrying capacity 
per millileter of blood decreased with the dextran infusion. 
However, increased flow probably compensated for this as 
evidenced by increased coronary sinus oxygen saturations of 
approximately 2Q%>, 
Experiment II (See Table 2, Figures 1,2) 
Using the same pyruvate assay procedure as in 
experiment I, all dogs, control and shock, were found to 
have negative pyruvate extractions at the start of this 
experiment. Excluding two dogs, one with negative lactate 
extraction and one that died during the experiment, the 
-'ic 
<.. 
, ' ' ‘ 
, O l ; jl 
• - • o c- •' . 
9 a 
co j 
r. ■ . ; C : ' 
■ • > ■! 
, ■ *>Y £• 
. 
45 
pyruvate extractions of the shocked dogs became even more 
negative during shock. The average pyruvate extraction of 
the shocked dogs before shock was -O.Q56um/ml while after 
shock it decreased to -0.135um/ml. The lactate extraction 
remained positive and increased from an average of 3.38mg$ 
to 11.60mg$ during shock. The change in pyruvate extraction 
was found to be statistically significant, pc.01. 
The pyruvate dehydrogenase activity of seven control 
dogs without thiamine pyrophosphate averaged .856I302 
A/2Gmin./mg N while five shock dogs averaged only .371-094. 
This difference was found to be statistically significant 
with probability <.01. The addition of thiamine pyrophos¬ 
phate to the assay resulted in an average shock enzyme 
activity of 4061.085 A/20min./mg N and a control value of 
.879^.284. Once again, the difference between control and 
shock samples was found to be statistically significant, 
probability <.01. 
Looking at just the control dogs in regard to changes 
in enzyme activity brought about by the addition of thiamine 
pyrophosphate, it appears that there was virtually no change 
(.8561.302 without and .8791,284 with). In the shock dogs, 
the addition of thiamine pyrophosphate resulted in an 
increase in activity from .3711.094 to ,4191,091, but this 
changes is not statistically significant, probability >.05. 
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Keeping the dogs on a respirator for one hour also did 
not seem to affect enzyme activity to a statistically signi¬ 
ficant degree. Controls with thiamine pyrophosphate averaged 
,923±.346 A/20min,/mg N before and .8341.195 A/20min./mg N 
after one hour on the respirator. Similar controls without 
thiamine pyrophosphate averaged .9191.372 A/20min,/mg N and 
.793-.188 A/20min,/mg N, before and after respectively. 
In both cases a paired t test revealed a probability >.05 
(not significant). 
Finally, the enzyme activity in apical and basal sample 
were compared with each other. In the control group, the 
average apex value was ,9211,359 A/20min./mg N and the basal 
left ventricular value ,8141,193 A/20min./mg N, In the 
shocked dogs, the apical value was also somewhat greater, 
,3931,072 A/20min./mg N compared to .3581.105 A/2Qmin./mg N 
These differences were not found to be statistically signi¬ 
ficant using a paired t test. 
Experiment III (See Table 3» Figures 3*^) 
Ten control dogs all exhibited negative pyruvate extrac 
tions (mean -0.0384 um/ml) and positive lactate extractions 
mean (12,Q5rag$) at the start of the experiment as in experi¬ 
ment II. After one hour on a respirator there was no change 
in either pyruvate or lactate extraction (-0,0380um/ral and 
11.66mg% respectively, p>,05). 
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Of the ten shock dogs, three developed negative lactate 
extraction after shock and will not be discussed further. 
The remaining seven had an original pyruvate extraction of 
“0.343um/ml, which did not differ from the control dogs. 
After shock, the pyruvate extraction became more negative 
(mean -0.l64um/ml). A paired t test shows this difference 
to be statistically significant, probability <,02. Lactate 
extraction was originally at a mean value of 9.85mg$ and 
increased slightly to l4,90mg$ during shock. The lactate 
extraction did not increase in every case and the differences 
were found not to be statistically significant, 
A comparison of the pyruvate dehydrogenase activity 
in left ventricular base samples between ten control and 
seven shock dogs revealed a mean of .4311.096 A/5min./mg N 
for the controls and .321+.086 A/5min,/mg N for the shocked 
dogs. This was found to be statistically significant, 
probability <.05, Five control base samples without thia¬ 
mine pyrophosphate had a mean enzyme activity of ,4531". 144 
A/5min»/mg N while that of comparable shock samples was 
.2731,080 A/5min./mg N. This difference was not statis¬ 
tically significant, but this may be due to the small samp¬ 
ling size. 
The mean enzyme activity of the shocked dogs’ apical 
samples, .3831,128 A/5min./mg N was not significantly dif¬ 
ferent from corresponding base samples, .3931,111 A/5min,/mg 
N, Control apical samples also did not differ statistically 
. 
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from base samples in enzyme activity (,3971.095 and ,4381,111 
respectively). In both groups however, base samples showed 
slightly greater activity. 
No effect was seen in regard to enzyme activity by the 
addition of thiamine pyrophosphate to shocked dogs9 left 
ventricular base assays. The mean value without thiamine 
pyrophosphate was ,273±.080 A/5min./mg N while with it it 
was ,292±,085 A/5min,/mg N, In control dogs too there was 
no difference. A mean of .423^.078 A/5min./mg N was 
obtained without thiamine pyrophosphate and .453-»l^ 
A/5min./mg N with it (probability >,05). 
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of spectrophotometrlc 
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DISCUSSION 
The most striking metabolic abnormality observed in 
these experiments Is the reversal of pyruvate extraction 
during early hemorrhagic shock. This finding is in agree¬ 
ment with the results of many other researchers!^'9^9 
O erk Cc: 
Some control dogs were found to have an initial 
negative pyruvate extraction. In all of these dogs the 
pyruvate A-V difference became statistically more negative 
during shock. Normal dogs with negative pyruvate extractions 
41 47 64 
have been reported elsewhere. * ' It has been observed 
that normal fasting dogs with low arterial pyruvate concern - 
64 
trations may have negative A-V pyruvate differences. The 
present studies indicate that regardless'of the initial myo¬ 
cardial pyruvate extraction, hemorrhagic shock persistently 
results in an increased pyruvate discharge by the myocardium. 
Several researchers^ have examined the problem of 
abnormal pyruvate metabolism in hemorrhagic shock and other 
conditions. They have focused much of their attention on 
thiamine metabolism and have concluded that a defect In 
cocarboxylase (thiamine pyrophosphate) is responsible for 
the observed abnormalities. 
Z £- 
Govier and Greer 9 explored the effect of thiamine 
administration on survival time in hemorrhagic shock. By 
bleeding ten untreated and ten treated dogs to a mean 
- 
. •>- ... X'[:<y.' 
. •-; . .■ ■. 
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arterial blood pressure of 45-60mm Hg, they found that the 
thiamine treated dogs survived 2,4 times longer than the 
untreated group. In 70% of the treated group, a rise in 
blood pressure from five to 50mm Hg was seen 30 minutes 
after thiamine administration, lasting for one hour. Since 
thiamine is essential in pyruvate metabolism, Govier and 
Greer^ also examined the blood levels of keto acids (pyru¬ 
vate, alpha-ketoglutarate and oxaloacetate) before and 
after thiamine administration. They found increased levels 
of keto acids in the serum of shocked dogs which subsequently 
fell after the administration of thiamine, indicating better 
6*7 
utilization of these substances. Govier ' further examined 
the correlation between plasma thiamine levels and resist¬ 
ance to shock in dogs. He found* a) greater resistance to 
shock in dogs with high thiamine levels prior to shocking, 
b) that dogs containing higher thiamine levels withstood 
more bleeding before developing severe hypotension, c) that 
dogs fortified with thiamine showed a consistent tendency 
to return to normal blood pressure after hemorrhage while 
other dogs remained hypotensive, and d) that the incidence 
of intestinal hemorrhage after bleeding is much greater in 
68 dogs with low thiamine content. Finally, Govier and Greig 
analyzed the biochemistry of thiamine utilization and noted 
that the phosphorylated form of thiamine (cocarboxylase) 
which acts as the coenzyme of pyruvate dehydrogenase is 
sensitive to hypoxia and can be destroyed by phosphotases in 
... 
. 
. .... ., .. . -u • - i ' ■ 
i : •: 
"• . ■ > 
, • 
• . .• •' ,0 
61 
the body. The demand for thiamine during hemorrhagic shock, 
they concluded, must be to counteract this phenomenon. 
Studying 11 control dogs and 19 shock dogs, they found a 
decrease in cocarboxylase in muscle, liver and duodenum dur- 
ing anoxia and hemorrhagic shock. Cocarboxylase (which 
diffuses out of cells once it is de-phosphorylated) could 
be re-synthesized in 30 to 60 minutes following the admin¬ 
istration of thiamine. A deficiency of cocarboxylase would 
prevent carbohydrates from entering the TCA cycle via the 
conversion of pyruvate to aeetyl-GoA, 
69 Chiba et al, y looked at myocardial metabolism in 
transplanted homograft dog hearts. Glucose extraction was 
positive but lactate extraction was occasionally negative 
and pyruvate extraction was always negative, as In hemor¬ 
rhagic shock. The respiratory quotient increased from 0.62 
to 1.90 indicating a conversion of carbohydrates to fats. 
The redox potential was positive Indicating the absence of 
anoxia. Thiamine hydrochloride was found to elevate the 
respiratory quotient and diminish the release of pyruvate 
from the myocardium. The authors hypothesize a block at 
the level of cocarboxylase following transplantation and 
that this block can be at least partially corrected with 
thiamine administration. The damage to cocarboxylase was 
probably not due to hypoxia but rather due to other patho¬ 
logic mechanisms occurring in rejection reactions (i.e. 
. 
. 
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antibody response). As rejection became accelerated, malic 
dehydrogenase and other enzymes were found to be lost from 
the myocardial cells due to impaired cellular permeability. 
70 Wendt et al, noted both negative myocardial lactate and 
pyruvate extraction in various myocardopathies such as idio¬ 
pathic and alcoholic but could give no reason for this 
occurrence. 
By employing a pyruvate dehydrogenase assay in the 
present study, it appears that the abnormal myocardial pyru¬ 
vate metabolism seen in hemorrhagic shock is not due to 
a defect in cocarboxylase, but rather a defect in the 
enzyme complex, pyruvate dehydrogenase, itself. In experi¬ 
ments II and III control left ventricular enzyme activity 
was found not to change over a one hour period on a respira¬ 
tor. Yet, shock dogs had a statistically lower enzyme activ¬ 
ity after one hour of hemorrhagic shock. There was no sta¬ 
tistical difference between apical and left ventricular 
basal samples taken from the same dog. The addition of 
thiamine pyrophosphate (cocarboxylase) to the assay did not 
correct the decreased activity found in shock samples. While 
a defect in both cocarboxylase and pyruvate dehydrogenase 
cannot be excluded, it is certain that the pyruvate dehydro¬ 
genase enzyme complex must be defective, and this alone could 
account for decreased pyruvate utilization with subsequent 
pyruvate discharge from the myocardium. Furthermore, thiamine 
administration has not been found to correct this abnormality. 
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It is interesting to speculate on the possible causes 
of the enzymatic damage. While decreased blood flow is the 
primary insult in hemorrhagic shock, hypoxia, acidosis, 
increased catecholamines and possibly peripheral toxins 
follow closely. Very little research has been devoted to 
the influence of these factors on cardiac metabolism. How¬ 
ever, certain correlations can be made between what is known 
of these factors in relation to survival, cardiac hemodyna¬ 
mics, cardiac metabolism, and the observations made in the 
present study, 
A. Hypoxia 
71 Crowell and Smith have related oxygen deficit (dif¬ 
ference between oxygen usage before and after shock) to 
survival. At an oxygen deficity of one hundred milliliters 
per kilogram all dogs survived, at one hundred and twenty 
milliliters per kilogram fifty per cent survived and at one 
hundred and forty milliliters per kilogram no dogs survived. 
The authors conclude that the amount of time spent in hemor¬ 
rhagic shock is not as important as the oxygen deficit and 
this explains why some animals seem to survive better than 
others» 
During periods of severe hypoxia, there is a build up 
of NADH in the myocardium which inhibits pyruvate dehydro¬ 
genase and forces a shift of pyruvate to lactate instead 
72 71 
of acetyl-CoA. Weil and Afifi'-' have found that oxygen 
" "a". • - 
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debt correlated best with the logarithm of lactate concentra¬ 
tion. Lactate concentration in turn correlated excellently 
with decreased survival. Studying 142 human patients, they 
noted that as the arterial lactate concentration increased 
from 2.1 to 8 millimoles per liter, survival decreased from 
74 90 to ten per cent. Huckabee has defined the term "excess 
lactate" to correlate myocardial lactate production with 
severe hypoxia. Excess lactate takes into account changes 
in lactate production due to pyruvate concentration changes. 
7 <5 
Griggs et al. have further shown that there is an oxygen 
gradient within the heart allowing one section (probably 
epicardium) to maintain oxidative pathways while other sec- 
tions (probably endocardium) must rely on anearobic path¬ 
ways. They used labeled lactate during periods of reduced 
blood flow to show that even while the myocardium is con¬ 
verting some lactate to carbon dioxide (labeled carbon dio¬ 
xide) endogenous lactate is being produced, 
rp /f 
Lemley and Meneely' have observed enzyme damage in 
hearts exposed to anoxic conditions. They report a 
decrease in coenzyme I and cytochrome c as well as a 
reduced rate of oxygen uptake in these hearts. Extracts 
of normal hearts were found to be capable of restoring pre- 
. 77 
viously anoxic hearts to normal, Danforth noted a 
decreased pyruvate extraction during anoxia but Scheuer and 
Brachfield^ report decreased fatty acid uptake with 
increased carbohydrate extraction and utilization. Shea 
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79 
et al, found a sudden increase in left atrial pressure 
(associated with heart failure) during lactate production 
by the heart under hypoxic conditions. 
It is noteworthy that the decreased activity of pyru¬ 
vate dehydrogenase described in the present study occurred 
during early hemorrhagic shock, before the myocardial pro¬ 
duction of lactate. At the time of negative pyruvate 
extraction, the arteriovenous lactate difference was 
actually greater than normal. Although there may have been 
severe hypoxia present in other organs, accounting for the 
increased arterial lactate concentration during shock, the 
increase in myocardial oxygen extraction (as evidenced by 
a decreased coronary sinus oxygen saturation in the presence 
of a normal or only slightly reduced arterial oxygen satura¬ 
tion) is probably responsible for preventing severe myo¬ 
cardial hypoxia and anaerobic metabolism. 
The possibility of a lesser degree of hypoxia cannot 
be excluded and therefore it may be instructive to look 
at the response of the heart to milder forms of ischemia, 
80 01 02 
Hackel et al, ’ * reduced the ambient oxygen content 
of unanesthetized dogs from 21 to ten and then to five per 
cent. At both ten and five per cent, coronary blood flow, 
heart rate and the oxygen extraction coefficient increased 
so that myocardial oxygen utilization was well maintained. 
At five per cent oxygen the pyruvate and lactate arterio¬ 
venous differences all decreased (despite increased arterial 
• - 
; • ■ . . ' . ' 
' 
■ Aw "lOV*: • i '.;i 3".i 
... , , -v 
, • . • X "i V oub 
‘'.'.r - as'Xxg 
i - ! ' '' 
,.. ■ . . : ■ ; i . 
. r ■ A . ■ • :0 
■ 
■if 
J ■ x ... 
. XJ 
, , 
66 
concentration). However, they never became negative and 
the increased coronary flow enabled total myocardial util¬ 
ization of these substances to remain normal. Only during 
complete anoxia was there a negative arteriovenous differ¬ 
ence in lactate accompanied by a further reduction in pyru¬ 
vate extraction (and in one case a negative pyruvate extrac 
tion). On the other hand, in hemorrhagic shock, it has 
already been mentioned that McKeever et al. * ^ could not 
prevent negative pyruvate extraction or irreversible shock 
from occurring despite maintenance of the coronary artery 
54 
circulation. Also Ratlif et al, used oxygen at high pres 
sures and still found no success in correcting the abnormal 
pyruvate metabolism. 
B. Acidosis 
Scheuer^ claims that excessive lactate production, 
associated with hypoxia, lowers intracellular pH and may 
84 damage enzymes or release lysosomes. Sehumer explored 
the problem of lactic acidosis in hemorrhagic shock. He 
infused normal dogs with lactic acid to the same concentra¬ 
tion as is found in irreversibly shocked dogs (7.99 milli¬ 
moles per liter) and found that all the animals died (at a 
pH of 6.81,04). Photomicrographs showed the same micro- 
circulatory picture as is seen in shock animals with a 65% 
blood loss (increased sludging, pooling, decreased flow), 
Goodyer et al,^ studied the effects of alkalosis and 
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acidosis on myocardial metabolism. Alkalosis tended to 
increase coronary artery flow, cardiac output, arterial 
lactate concentration and arterial pyruvate concentration. 
Coincident with this, there was an increased uptake of 
lactate and pyruvate, and an increased utilization of lac¬ 
tate as an energy source. Acidosis tended to reduce core- 
nary flow, cardiac output and myocardial oxygen consumption 
and increase the arterial glucose concentration. Although 
the concentration of glucose rose significantly, the myo¬ 
cardial extraction of glucose did not change, representing 
an inability to extract high levels of glucose during aci¬ 
dosis, Pyruvate and lactate extraction decreased. How¬ 
ever, the proportion of energy yielded by carbohydrates 
was still high during acidosis and cardiac efficiency was 
not appreciably altered. 
8 6 Baue et al, while agreeing that acidosis in the iso¬ 
lated heart decreases myocardial contractility, reduces 
heart rate and decreases cardiac responsiveness to epine¬ 
phrine and norepinephrine, showed that there were no sig¬ 
nificant differences in hemodynamic responses or oxygen 
consumption in shocked dogs treated with either sodium 
bicarbonate or sodium chloride, although the former returned 
the pH to normal (?.l6 to 7.38). Nelson et al,^ similarly 
showed by using the experimental drug tris (hydroxy-methyl) 
aminomethane, a powerful alkalinizing and diuretic agent, 
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that correction of pH alone does not increase survival in 
hemorrhagic shock. 
During the period of increased negative pyruvate 
extraction and decreased pyruvate dehydrogenase activity 
described in this study, increased systemic lactate con¬ 
centration and decreased pH were observed. Yet administra¬ 
tion of dextran corrected the negative pyruvate metabolism 
(at least temporarily) without changing the pH while admin¬ 
istration of thiamine with sodium bicarbonate did not. 
Though this does not conclusively rule out the role of aci¬ 
dosis in damaging myocardial pyruvate metabolism, it does 
support the findings of Baue’s and Nelson's groups. Since 
the pyruvate dehydrogenase enzyme was assayed under optimal 
in vitro conditions, including a potassium phosphate buffer, 
any enzyme damage due to acidosis would have been long 
lasting. 
C. Catecholamines 
Neither a review of the literature nor the experiments 
in this study can conclusively ascertain whether increased 
catecholamines in the circulation can cause myocardial 
damage on a biochemical level. The role of hyper-contractil¬ 
ity and tachycardia in producing anatomical lesions of the 
2Q 30 31 
myocardium has already been discussed. - The in vitro 
pyruvate dehydrogenase assay may be helpful in resolving this 
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problem by assaying left ventricular samples from dogs with 
and without heart block and/or beta blockade during hemor- 
rhagic shock, 
88 Goodale and Haekel ' examined myocardial metabolism 
during periods of severe stress, when circulating adrenalin 
levels were very high, and found that lactate extraction 
to a major degree and pyruvate extraction to a minor degree 
89 
were decreased. Haekel et al. explored the effect of 
hypotension due to spinal anesthesia on myocardial metabo¬ 
lism. They noted that in a situation where reduced blood 
pressure led to a diminished coronary flow but no adrenalin 
release, glucose, lactate and pyruvate extractions all 
remained normal. 
90 Simeone et al. used a platinum electrode to measure 
oxygen tension in myocardial tissue during hemorrhagic 
shock with and without 1-norepinephrine Infusions. They 
found that if 1-norepinephrine is given during the first 
five minutes of shock (before permanent damage due to 
hypoxia), not only is per cent survival increased, but oxy¬ 
gen tension in the myocardium Is increased to 13# greater 
than normal during the infusion and slightly less than nor- 
mal afterwards. This Is opposed to a 6l# decrease without 
the use of 1-norepinephrine. The authors emphasize that 
they feel 1-norepinephrine is helpful in early hemorrhagic 
shock but may be ineffective or even injurious if given 
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91 later in the course of hemorrhagic shock. Calxva et al. 
used electropolarography to continuously record the avail- 
ability of oxygen between the capillaries and muscle cells. 
They found that the oxygen availability fell during hemor¬ 
rhagic shock to zero at a blood pressure of twenty milli¬ 
meters Hg and that in early hemorrhagic shock any means of 
increasing flow (norepinephrine, dextran, plasma or blood) 
led to a restoration of normal oxygen availability. Thus 
any damage done to the myocardium on the basis of hypoxia 
92 
could hopefully be prevented, Gatchpole' found treatment 
with norepinephrine after 45 minutes of shock increased 
blood pressure, coronary blood flow and oxygen utilization 
without further increasing peripheral vasoconstriction. 
However the mortality remained the same with or without 
norepinephrine because of fatal cardiac arrhythmias induced 
by the norepinephrine infusion. 
93 94 Entman et al. found a greater systolic blood flow 
and decreased incidence of subendocardial necrosis when 
shock dogs were treated with pronethalol (a beta blocker). 
95 Baue et al. contradict the significance of Entman’s results 
by claiming increased survival (though not statistically sig¬ 
nificant) and increased cardiac output plus less mesenteric 
damage in dogs bled to thirty millimeters Hg and treated 
with isoproterenol (a beta stimulator). 
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D, Peripheral Toxins 
The possibility of a peripheral toxin as discussed by 
1 O g 
Goodyer, Lefer, and Lillehei also cannot be ruled out. 
Although several different end-organs and types of toxins 
have been hypothesized, all authors agree that peripheral 
ischemia is the initiating factor. Based on this assumption, 
one would expect harmful effects from systemic vasoconstric¬ 
tors during shock and helpful effects with the use of vaso¬ 
dilators, Most of the experimental work on this subject 
unfortunately remains inconclusive. 
96 Opdyke bled dogs to a mean arterial blood pressure 
of fifty millimeters Hg for 90 minutes, then re-bled them 
to thirty millimeters Hg, After three minutes he infused 
neo-synephrine to increase the blood pressure to between 
fifty and seventy-five millimeters Hg for 45 minutes and 
then transfused all dogs with their own blood. The average 
length of survival of the treated dogs was 13.4 hours while 
that for the untreated dogs was only 5.3 hours. He concluded 
that any peripheral damage that might be done by intense 
vasoconstriction is more than compensated for by Increased 
flow through vital centers, thereby increasing survival time, 
A contrary view Is held by Hackelyr who infused 1-norepine¬ 
phrine after 45 minutes of shock and noted no increased sur¬ 
vival or cardiac output but did notice increased peripheral 
vascular resistance. All of these parameters could be 
corrected by infusing whole blood. He subscribes to the 
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theory that peripheral ischemia may cause the release of a 
98 
toxin which can affect myocardial enzyme systems. Hackel' 
also observed an increased incidence of subendocardial hemor- 
rhage in shock dogs treated with 1-norepinephrine, probably 
due to the increased work load placed on the heart. Remington 
99 . ■ . 
et al. found a seven to nine times greater survival in dogs 
pre-treated with dibenamine (a sympathetic blocker-vasodila¬ 
tor). They hypothesize that dibenamine prevents low flow to 
a vital organ during shock which is necessary for survival. 
Weil and Whighan100 discovered an increased survival in rats 
given 100 times the replacement dose of glucocorticoids and 
ascribed this to the vasodilatory effects of steroids. 
Danoff and Greene,however, report increased excess lac¬ 
tate with hexamethonium (a ganglionic sympathetic blocker- 
vasodilator) and Glasser and Page notes no increase in 
survival with the use of tetramethyl ammonia (a sympathetic 
blocker-vasodilator). 
Further studies along these lines could be accomplished 
by examining dogs in whom the systemic circulation is main¬ 
tained while the coronary circulation remains at shock levels 
and vice versa. The release of peripheral toxins would be 
expected to occur only during systemic ischemia. Assaying 
for pyruvate dehydrogenase activity under these circumstances 
may demonstrate what relationship, if any, exists between 
peripheral toxins and myocardial enzyme damage. Similarly, 
one could directly assay the effect of plasma from shocked 
r. ., 
■ 
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dogs on the pyruvate dehydrogenase activity of left ventric- 
ular samples from normal dogs. 
Summary 
The present study highlights one early metabolic derange¬ 
ment of the myocardium during hemorrhagic shock. The signifi¬ 
cance of this defect and its possible causes can only be 
presently guessed at. Since the decreased activity of the 
pyruvate dehydrogenase enzyme complex occurs during a period 
of aerobic myocardial metabolism (before lactate production) 
one would expect deficient or inefficient energy production. 
It is worthwhile noting that several researchers have described 
24 2 5 
a decrease in myocardial performance during shock r9 and 
that the role of myocardial failure in irreversible shock 
remains to be settled. A reduction in the activity of pyru¬ 
vate dehydrogenase may be one of the early signs of myocardial 
damage and understanding the causes of this reduced activity 
(acidosis, catecholamines, hypoxia or toxins) may eventually 
lead to a more precise understanding of the patho-physiology 
of hemorrhagic shock and to better modes of treatment. 
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CONCLUSION 
The following observations have been made in this studys 
1. Within one hour after hemorrhagic shock in dogs 
(b.p, 25-45mm Hg) the myocardial arteriovenous pyruvate 
difference either becomes negative or if negative to start 
with, becomes significantly more negative. At the same 
time, the myocardial arteriovenous lactate difference 
remains positive. 
2. During hemorrhagic shock, myocardial oxygen extrac¬ 
tion is increased, arterial lactate and pyruvate concentra¬ 
tions are increased, and arterial pH is decreased. 
3. Infusions of thiamine hydrochloride or cocarboxy¬ 
lase during hemorrhagic shock does not correct the negative 
myocardial pyruvate extraction. 
4. Infusions of 6% dextran in normal saline, which 
returns the mean arterial blood pressure to normal, corrects 
the negative myocardial pyruvate extraction at least tempor¬ 
arily. 
5. Returning shed blood after three hours of hemor¬ 
rhagic shock can sometimes restore positive myocardial pyru¬ 
vate extraction, 
6. A method of assaying the pyruvate dehydrogenase 
enzyme complex in myocardial tissue has been established. 
■ 
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This assay is based on the photometric change observed as 
ferric ions are reduced to ferrous ions and is expressed as 
delta A/5min./mg N, 
7. After one hour on a respirator, there is no chang 
in left ventricular pyruvate dehydrogenase activity but 
after one hour of hemorrhagic shock, this activity is sig¬ 
nificantly decreased in both apical and basal left ventricu 
lar samples. 
8. Exogenous cocarboxylase added to the assay does 
not affect enzyme activity. 
9. Decreased pyruvate dehydrogenase activity may 
represent an early form of myocardial damage during hemor¬ 
rhagic shock. Acidosis, hypoxia, catecholamines and periph 
eral toxins have been discussed as possible causes of this 
damage. 
10. In the future, pyruvate dehydrogenase and other 
enzyme assays may be used to determine which agents are 
responsible for myocardial damage and perhaps irreversible 
hemorrhagic shock. Derangements in myocardial metabolism 
may precede contractility or hemodynamic impairments. Fur¬ 
ther study of myocardial metabolism is encouraged. 
. 
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Experiment II 
Left Ventricular Enzyme Activity 
( A/20min./mg N) 
Apex Base* 
Dog •+TPP -TPP 
Before Shock 
+TPP -TPP 
1C .601 .520 
.719 .7 08 
2C .590 .590 .671 .731 
3C .869 »862 .769 . 660 
4C 1.604 .1.590 1.224 1.230 
5C .922 .868 .871 .794 
6C 1.222 1,344 .980 .800 
7C . 662 , 662 .610 .630 
After Shock 
IS 
.303 .316 ,408 .399 
2S .382 .481 .540 .462 
3S** .259 .224 .536 .505 
4S 
.495 .500 ,248 .215 
5S*** .749 .740 ,1210 .1020 
6S 
.329 .329 .462 .308 
7S .454 .438 
.279 .250 
*After one hour on a respirator 
died during experiment 
Negative lactate extraction during shock 
■ J Vi.C*f • £ A • 
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Experiment II 
Pyruvates (um/ml) 
Dos; 
Before Shock 
Art. C.S. A-V Diff. Art. 
After Shock 
C.S. A-V Diff, 
1C 
2C 
3C 
4C 
.0155 .0608 ”.0453 
5C .0586 .0877 ”.0291 
6c .0421 .0314 
-.0107 
7C .0325 .0796 ”.0471 
IS .0958 ,1815 -.0857 .0576 .1962 -.1386 
2S .2069 ,2814 ”.0745 .1322 .1895 ".0573 
3S .0863 ,1396 
-.0533 Dog Died 
4S .0168 .1065 ”.0897 .0475 .1637 -.1162 
5S ,0822 .1876 ”,1054 
.0287 .1507 -.1220 
6s .1170 .0860 0.031 .0420 .2020 -0.160 
7S .0029 .0649 >,0612 ,0908 
.3954 -.2046 
xr . 
• •** v i •«’* c-i. 
.. - ■ 
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Experiment II 
Lactates (mg/lOOml) 
Before.Shock After Shock 
DO£ Art, C.S. 
1C 
2G 
3C 
4C 11.136 6.518 
5C 31.883 20.114 
6C 8.069 4.077 
7C 15.737 8.728 
IS 13.970 14.984 
2S 38.599 30.027 
3S 20.230 15.600 
4S 9.197 4.687 
5S 47.383 46.981 
6s 36.590 18.150 
73 8.602 7.216 
•vr-3s* sample lost 
A-V Dif f, Art, 
4.618 
11.769 
3.992 
7.009 
-1,014 54.169 
8.572 55.756 
4. 630 
4.510 29.697 
0.402 75.891 
18.440 
1.386 86.521 
C.S. A-V Piff. 
39.320 14.849 
38.498 17.258 
Dog Died 
22.53? 7,160 
90.624 -14.733 
88.630 
79.499 7.022 
‘ 
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Experiment II 
Dog. 
Before 
Art. 
% °2 
Shock 
C.S. 
Sat. 
After 
Art. 
Shock 
C.S. 
B.P. 
Before 
Art. 
(mraHg) 
After 
Art. 
Approx. 
Blood 
Loss (cc) 
1C 
2C 
3C 
4C 94 28 116.5 
5C 98 39 174 
6c 92 30 139 
?C 96 25 121.5 
IS 100 52 98 30 117 43-47 600 
2S 100 49 100 20 97 25-44 550 
3S 99 50 Dog Died 125 30-47 62 0 
4S 99 30 94 <20 95 31-38 650 
5S 96 41 93 <20 71 23-45 560 
6S 95 32 93 <20 75 24-31 650 
7S 96.5 26.5 4 5 <20 145 37-4-7 550 
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Experiment III 
Pyruvates (um/ml) 
(control dogs) 
Before 1 Hour After 1 Hour 
Dog, Art. c.s. A-V Diff, Art. C.S. A-V Diff. 
1C 0.0568 0,0611 -0.00534 0.0951 0,1083 -0.01318 
2C 0.0557 0,0405 +0.0152 0.1130 0.1570 -0,0440 
3C 0.0267 0.1751 -0.1484 0.1855 0.2934 -0.1079 
4C 0’1026 0.1431 -0.405 0.2241 0.1009 0.1232 
5C 0.0277 0.0878 -0,06018 0.0186 0.0168 0.001783 
6C 0.1243 0,0945 +0.0298 0.0247 0,0337 -0.0090 
7C 0.1996 0.0872 +0.1124 0.1287 0.2902 -0.1615 
8C 0.2391 O.2698 -0.0307 0.0255 0.1229 -0,0974 
9C 0.2344 0.1608 +0.0736 0.1087 0.1374 -0.0287 
IOC 0.0931 0.0592 +0.0339 0.0341 0.0586 -0.02457 
■ 
i:. 
. 
- 
■ 
Experiment III 
9 4 
Pyruvates (um/ral) 
(shock dogs) 
Before Shock After Shock 
DO£ Art. C.S. A-V Diff, Art. C.S. A-V Diff. 
IS 0.0452 0.1714 +0.12613 0,0976 0.2642 -0.16660 
2S 0.1258 0.1295 -*0.0037 0.3596 0.3279 0,0317 
3S 0.0784 0.1095 -0.0311 0.0704 0.1642 -0,0938 
4S 0.0185 0.1146 -0.09608 0.0502 0.1807 -0.13044 
5S 0.0390 0,1221 -0,0831 0.1456 0.2291 
-0.0835 
6s 0.1335 0,1801 —0,0466 0,0551 0.3690 -0.3139 
7S 0.2539 0.1462 0.10762 0.1297 0,2363 -0,10656 
8S 0.1822 0,2455 -0,0633 0,0579 0.1742 -O.II63 
9S 0.1682 0.2385 -0.0703 0,0163 0.1194 
-0.1031 
10S 0.1861 0.1451 -0.04100 0,0148 0.3001 -0.28521 
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Experiment III 
Lactates (mg/lOOml) 
(control dogs) 
Before 1 Hour 
Dog Art, C.S. A-V Di: 
1C 23.' 247 14.145 9.102 
2C 18.423 19.239 -0,816 
3C 43.133 31.849 11.284 
4C 53.054 35.871 17.183 
5C 52.044 44.430 8.214 
6C 33.895 15.705 18,190 
7C 42.703 32.408 10.295 
8C 69.446 49.318 20.128 
9C 69.933 52.221 14.712 
IOC 22.313 10.110 12,203 
Art. 
After 1 
C.S. 
Hour 
A-V Diff. 
24.209 11.203 13.006 
28.521 21.032 7.499 
46.448 28.59? 17.851 
40.171 17.559 22.612 
30.998 25.582 5.416 
16.844 6.775 10,069 
41.479 32.446 9.033 
69.305 59.095 10.210 
61.118 49.113 12.005 
18.983 9,796 9.187 
' ;< .v' 
. 
r , - 
v ■ 
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Experiment III 
Lactates (mg/lOOml) 
(shock dogs) 
Dog 
.Before Shock 
Art. C.S. A-V Diff. 
IS 41.170 37.447 3.55228 
2S 91.139 101.827 -10,688 
3S 27.339 17.290 10,049 
4S 57.087 49.418 7.669 
5S 44.294 26.803 17.491 
6s 11.499 10.097 1.452 
7S 70.236 32,437 37.899 
8S 30.361 30,724 -0.363 
9S 61.828 50,321 11.5075 
10S 27.257 25.407 1.850 
After Shock 
Art. C.S. A-V Diff. 
109.737 123.857 -14,12065 
117.585 132.977 -15.392 
87.777 
103.745 89.329 14,416 
81.214 91.164 
-9,950 
109.024 100.536 8,488 
99.981 79.387 20.594 
99.517 85.766 13.751 
113.146 111.062 2,0843 
84.027 54.115 29.912 
sample lost 
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Experiment III 
% O2 Sat. B.P. (mmHg) 
Dog 
Before Shock 
1 Hour 
Art. C.S. 
After Shock 
1 Hour 
Art, C.S. 
Before 
Art, —- 
After Approx. 
Blood 
-4 Art. Loss (cc) 
1C 95 43 96 47 80 80 
2C 97 43 97 43 115 112.5 
3G 99.5 36 100 40 105 80 
4C 99 37 99 36 80 85 
5C 99 34 99 36 105 90.5 
6c 98 33 96 34 120 127.5 
7C 97 35 99 36 71.5 70 
8C 93 53 92 51 75.5 66,5 
9C 94 53 95 57 90.5 90 
IOC 93 42 92 42 113.5 125 
IS 99 45 98 29 120 35-39 700 
2S 98.5 49 99 37 24=37 360 
3S 99 36 99 25 100 28=37 620 
4S 97 37 97 32 101 35-50 830 
5S 100 43 99 21 131 21 = 30 600 
6s 99 24 87.5 27 118 22=40 600 
7S 99 36 98 33 89 36=47 600 
8S 99 27 98 37 82 28-33 400 
9S 94 49 94 44 77 19-30 250 
10S 94 55 93 37.5 95 32=34 450 
^'partially occluded catheter, inaccurate reading 
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